Femara (letrozole) or Arimidex (anastrozole) for breast cancer
February 2001
More women will be taking Femara (letrozole) or Arimidex (anastrozole) for breast cancer.
Both are now approved for INITIAL therapy of metastatic breast cancer...as an alternative to tamoxifen.
Until now, tamoxifen was the gold standard for treating women with estrogen-receptor positive breast cancer. But Femara and Arimidex seem to work at least as well...if not better.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote